Desmoplastic small round cell tumour: A description of two cases and review of the literatureLIPPE, Paolo; BERARDI, Rossana; CAPPELLETTI, Claudia et al.Oncology. 2003, Vol 64, Num 1, pp 14-17, issn 0030-2414, 4 p.Article

Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimensMASSACESI, Cristian; PISTILLI, Barbara; VALERI, Michele et al.American journal of clinical oncology. 2002, Vol 25, Num 2, pp 140-148, issn 0277-3732Article

Mutations of hMLH1 and hMSH2 in Patients with suspected hereditary nonpolyposis colorectal cancer: Correlation with microsatellite instability and abnormalities of mismatch repair protein expressionSCARTOZZI, Mario; BIANCHI, Francesca; ROSATI, Saverio et al.Journal of clinical oncology. 2002, Vol 20, Num 5, pp 1203-1208, issn 0732-183XArticle

Clinical benefit of gemcitabine-cisplatin in advanced non-small cell lung cancer elderly patientsLIPPE, Paolo; SILVA, Rosa R; GIULIODORI, Luciano et al.Anticancer research. 2002, Vol 22, Num 2B, pp 1053-1059, issn 0250-7005Conference Paper

Identification of clinical prognostic factors in patients with unknown primary tumors treated with a platinum-based combinationPIGA, Andrea; GESUITA, Rosaria; CARLE, Flavia et al.Oncology. 2005, Vol 69, Num 2, pp 135-144, issn 0030-2414, 10 p.Article

Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional featuresBELVEDERESI, Laura; BIANCHI, Francesca; PORFIRI, Emilio et al.European journal of human genetics. 2006, Vol 14, Num 7, pp 853-859, issn 1018-4813, 7 p.Article

Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology GroupDAPONTE, Antonio; ASCIERTO, Paolo A; GRAVINA, Adriano et al.Cancer. 2000, Vol 89, Num 12, pp 2630-2636, issn 0008-543XArticle